Phase II Trial of 9-Aminocamptothecin (9-AC) Colloidal Dispersion (CD) 120-Hour Continuous Intravenous Infusion in Advanced Non-Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 13 Apr 2010
At a glance
- Drugs IDEC 132 (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 26 Feb 2010 New trial record